Colon cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Colon cancer
May 19, 2025, 04:51 | Stories
Mass General Cancer Center Shared Dawn Quadir's Story with Stage 3 Colorectal Cancer
Mass General Cancer Center shared a post on LinkedIn: "Dawn Quadir's symptoms started with blood…
May 10, 2025, 09:40 | Blog
Promising New Drug Combination for Colon Cancer Resistant to Standard Treatments
City of Hope shared a post on LinkedIn: "A Phase 3 clinical trial shows promise…
May 9, 2025, 07:19 | Drugs
Jenny Seligmann: FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients
Jenny Seligmann, Professor of Gastrointestinal Oncology at the University of Leeds, shared a post by…
May 1, 2025, 12:22 | Blog
Fight Colorectal Cancer: Colon cancer is on the rise—but so is progress
Fight Colorectal Cancer shared a post on LinkedIn: "Colon cancer is on the rise—but so…
Apr 30, 2025, 08:37 | Blog
Raphael E. Cuomo: Risk of death increased over twenty-fold in colon cancer patients with cannabis use disorder
Raphael E. Cuomo, Professor and Scientist at University of California, posted on LinkedIn: "Risk of…
Apr 18, 2025, 08:05 | Oncolibrary
South Korean Scientists at KAIST Reprogram Colon Cancer Cells in Breakthrough That Could Change Oncology
For decades, the cornerstone of cancer treatment has relied on strategies aimed at destroying malignant…
Apr 17, 2025, 17:02 | Blog
Daniel Flora: New targeted therapy combined with chemotherapy for metastatic colon cancer
Daniel Flora, Medical Director of Oncology Research at St. Elizabeth Healthcare, shared a post on…
Apr 15, 2025, 17:01 | Blog
Nicholas Hornstein: Aspirin can prevent colon cancer?
Nicholas Hornstein, GI Medical Oncologist at Northwell Health, shared on X a reccent paper by…
Apr 8, 2025, 19:53 | Oncolibrary
FDA Approves Nivolumab and Ipilimumab for Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer: CheckMate 8HW trial results
Ipilimumab and nivolumab combination, ​On April 8, 2025, twas approved by he U.S. Food and…
Apr 8, 2025, 12:46 | Blog
Emanuela Palmerini Joins Sylvester Comprehensive Cancer Center Sarcoma Team
Sylvester Comprehensive Cancer Center shared a post on LinkedIn: "Dr. Palmerini specializes in Ewing sarcoma…
Apr 4, 2025, 09:40 | Blog
Jennifer Buell: BOTENSILIMAB is changing treatment landscape in MSS colon cancer
Jennifer Buell, President and Chief Executive Officer of MiNK Therapeutics and Executive Council at Agenus,…
Apr 3, 2025, 12:42 | Blog
NCCN updates guidelines, favoring DPYD testing for colon, anal, rectal, and small bowel cancers - Precision Medicine
Precision Medicine shared a post on LinkedIn: "The National Comprehensive Cancer Network (NCCN) has updated…
Apr 3, 2025, 05:10 | Blog
Toufic Kachaamy: Thank you Rizwan Jafri and Colon Cancer Coalition for raising awareness about Colon Cancer
Toufic Kachaamy, Chief of Medicine and Medical Director of Gastroenterology at City of Hope Phoenix, shared…
Mar 25, 2025, 17:52 | Blog
Aakash Desai: Interesting innovation in colon cancer therapy
Aakash Desai, Associate Director of Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive…
Mar 25, 2025, 11:52 | Science
Catherine Alix-Panabières: The proteomic profile of EVs released by metastasis-competent CTCs in colon cancer
Catherine Alix-Panabières, Professor of Oncology at the Faculty of Medicine of the University of Montpellier,…
Mar 25, 2025, 06:33 | Blog
Catherine Alix-Panabières: Proteomic Profiling and Functional Analysis of Extracellular Vesicles in Colon Cancer Metastasis
Catherine Alix-Panabières, Professor of Oncology at the Faculty of Medicine of the University of Montpellier,…
Mar 24, 2025, 11:55 | Blog
Michel Ducreux: I am very proud to be one of the members of the Blue March campaign
Michel Ducreux, University Professor-Hospital Practitioner at Paris-Saclay University, shared on LinkedIn: "I am very proud…
Mar 23, 2025, 06:35 | Celebrities
James Van Der Beek: Battle with Colorectal Cancer and Marriage Challenges During Treatment
"I am worthy of God's love simply because I exist. And if I'm worthy of…
Mar 22, 2025, 08:43 | Blog
Richard Sassun: It is time to give Tumor Deposit a proper role in the staging
Richard Sassun, Colorectal Surgery Fellow at Mayo Clinic Rochester, reshared a post by JAMA Surgery on…
Mar 19, 2025, 11:01 | Celebrities
In Memory of Chadwick Boseman and His Colon Cancer Battle
How One Life Changed Colon Cancer Awareness Chadwick Boseman was an iconic actor whose portrayal…
Mar 19, 2025, 07:50 | Blog
Kelley Wood: Can exercise optimize cancer survival rates?
Kelley Wood, Director of Research at ReVital Cancer Rehabilitation, reshared a post by American Cancer Society…
Mar 12, 2025, 06:58 | Blog
Elvina Almuradova: CtDNA-guided approach for ACT in stage II colon cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Mar 11, 2025, 08:32 | Science
Nicholas Hornstein: DYNAMIC out now with 5 year data Stage II colon cancer
Nicholas Hornstein, Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell,…
Mar 6, 2025, 07:26 | Blog
Toufic Kachaamy: Raising Awareness at the Colon Cancer Coalition Walk
Toufic Kachaamy, Chief of Medicine and Medical Director of Gastroenterology at City of Hope Phoenix, shared…
Mar 5, 2025, 11:47 | Blog
Neil D. Parikh: Colon Cancer and EndoOncology with Toufic Kachaamy
Neil D. Parikh, Chief Innovation Officer and Gastroenterologist at CONNECTICUT GI, P.C., shared a post…
Mar 1, 2025, 15:12 | Science
Elvina Almuradova: Exercise and Colon Cancer Survival
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Mar 1, 2025, 13:01 | Blog
Gertjan Rasschaert: First patient dosed worldwide today in AZUR4 at UZ Leuven
Gertjan Rasschaert, Medical Doctor and Consultant specializing in Gastrointestinal Oncology and Gastroenterology at UZ Leuven,…
Feb 25, 2025, 10:33 | Science
Nicholas Hornstein: Checkpoint inhibition in dMMR colon cancer is the future
Nicholas Hornstein, Hematologist and Oncologist with Northwell Health, shared an article by Benoit Rousseau, et…
Feb 24, 2025, 15:25 | Blog
Bibhudatta Mishra: A paradigm shift in oncology
Bibhudatta Mishra, Clinical Development Leader at Neuronity, shared a post on LinkedIn:  "Scientists at KAIST…
Feb 22, 2025, 15:14 | Science
Erman Akkus: Stage specific characterization of early-onset colorectal cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared an article on X: "Our study…
Feb 22, 2025, 11:40 | Celebrities
Remembering Saxophonist James Casey: His Battle with Colon Cancer and Advocacy
James Casey, the celebrated saxophonist best known for his electrifying performances with the Trey Anastasio…
Feb 19, 2025, 16:51 | Science
Evelyn Wong: Early Onset Colorectal Cancer – Can we do more?
Evelyn Wong, Medical Oncologist at National Cancer Centre Singapore, shared her recent article on LinkedIn: …
Feb 17, 2025, 09:10 | Science
Elvina Almuradova: Can yogurt lower colon cancer risk?
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Feb 9, 2025, 18:33 | Insight
Jennifer Lovick: The latest research from technology in cancer research and treatment's January round-up
Jennifer Lovick, Executive Editor of Technology in Cancer Research and Treatment at Sage, shared a…
Feb 3, 2025, 16:23 | Science
New Review on ctDNA in Early-Stage Colon Cancer by Rami Yanes et al.
Applonia Rose, Managing Editor at Sage Publishing, shared an article by Rami Yanes, et al.…
Jan 25, 2025, 15:56 | Blog
No recurrences in MSS colorectal cancer with BOT/BAL neoadjuvant immunotherapy: NEST Trial updates from ASCOGI25
The NEST Trial, conducted by Agenus, was presented with latest updates at the ASCO GI…
Jan 21, 2025, 14:11 | Blog
Ibrahim Halil Sahin: ctDNA and its role on future management of early stage colon cancer
Ibrahim Halil Sahin, Assistant Professor at UPMC Hillman Cancer Center, shared a post on X:…
Jan 14, 2025, 12:52 | Science
Jenny Seligmann: Time to re-think targeted agents in LACC/LARC
Jenny Seligmann, Professor of Gastrointestinal and Translational Oncology and Honorary Consultant in Medical Oncology at…
Jan 12, 2025, 07:07 | Insight
Elvina Almuradova: ctDNA/MRD testing shows promise in guiding colon cancer treatment
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Jan 1, 2025, 17:31 | Science
Hung Trinh: Natera Announces Enrollment of First Patients in SAGITTARIUS
Hung Trinh, Senior Director of Business Development at OBiO Tech, posted on LinkedIn: "Natera Announces…
Dec 27, 2024, 16:33 | Insight
The Korea Advanced Institute of Science and Technology reversed the malignant state of colon cancer cells
Korean researchers have made a discovery in cancer treatment by successfully manipulating genetic switches in…
Dec 20, 2024, 01:30 | Blog
Michael Sapienza: We are at the closest time for progress and a cure for Colon Cancer
Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, shared a post on LinkedIn:…
Dec 9, 2024, 14:36 | Blog
Andrew Albert and Craig Eagle discuss the new SHIELD screening blood test for colon cancer - Doctor Podcasts
Doctor Podcasts shared a post on X: "Colon cancer strikes ~ 150,000 people in the…
Dec 7, 2024, 02:08 | Insight
Katsuaki Maehara: Is the colon an organ that differs from the right side to the left side?
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X: “Molecular Cancer. Is…
Dec 2, 2024, 09:57 | Blog
Michael Shusterman: GI Oncology standard regimen doses remain too high for many real world patients
Michael Shusterman, Medical oncologist and Clinical Assistant Professor of Medicine in the Permutter Cancer Center…
Nov 26, 2024, 10:28 | Blog
Luis Diaz Received the ISLB 2024 Lifetime Achievement Award
Luis Diaz Received the ISLB Lifetime Achievement Award at the 6th Annual Congress of Liquid…
Nov 22, 2024, 21:38 | Blog
Erman Aytac: Confer 2024 - one of the largest and most prestigious cancer meeting of Romania
Erman Aytac, General Surgery Clinic Chief of Acibadem University Atakent Hospital, posted on X: "Confer…
Nov 19, 2024, 20:48 | Insight
Jun Gong: ctDNA-guided adjuvant immunotherapy in stage III MSI-H dMMR colon cancer
Jun Gong, Medical Oncologist and Researcher at Cedars-Sinai Medical Center, shared a post on X…
Nov 16, 2024, 15:57 | Insight
Neoadjuvant nivolumab and relatlimab in locally advanced MSI CRC
Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and…
Nov 11, 2024, 19:33 | Celebrities
Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More
During the second season of The Osbournes, Sharon allowed cameras to document her battle with…
Nov 11, 2024, 15:20 | Insight
Annalice Gandini: The prognostic impact of pT4 N0 colon cancer
Annalice Gandini, Medical Oncology Specialist at the San Martino Polyclinic Hospital, shared a post on…
Nov 10, 2024, 01:21 | Insight
Annalice Gandini: Genetic and transcriptomic analyses of early-onset colon cancer
Annalice Gandini, Medical oncologist resident at the Ospedale Policlinico San Martino in Genoa, shared her…
Nov 3, 2024, 12:38 | Blog
Beliz Bahar Karaoğlan: Is 3 months of adjuvant chemo enough for all low-risk stage III colon cancer patients?
Beliz Bahar Karaoğlan, Medical Oncology Fellow at Ankara University, shared on X about recent paper…
Nov 2, 2024, 15:51 | Immune Oncology
Immunotherapy for Metastatic Colon Cancer: Types, Success Rate, Side Effects & More
Immunotherapy has emerged as a promising treatment option for colon cancer, particularly for patients with…
Oct 29, 2024, 15:14 | Blog
Honoring Rodolfo Franklin's Legacy
Rodolfo Antonio Franklin II, known professionally as DJ Clark Kent, was an American hip hop…
Oct 22, 2024, 18:29 | Immune Oncology
Immunotherapy for Colon Cancer: Types, Success Rate, Side Effects & More
Immunotherapy is emerging as a significant treatment option for colon cancer, particularly for patients with…
Oct 13, 2024, 10:44 | Insight
Sharlene Gill: Duration of adjuvant treatment in Stage III colon cancer
Sharlene Gill shared a post on X: "Duration of adjuvant treatment in s3 colon cancer in…
Oct 9, 2024, 14:10 | Stories
David Thau's Journey with Colon Cancer: From Patient to Advocate
What motivated David Thau to become one of the top fundraisers? David Thau is recognized…
Oct 7, 2024, 16:28 | Insight
Erman Akkus: Neoadjuvant IO in colon/rectal cancers
Erman Akkus posted on X: “Neoadjuvant IO in colon/rectal cancers. pCR rates. Grade 3/4 irAE.…
Sep 26, 2024, 15:41 | Blog
Mark Lewis: The 'trolley problem' of adjuvant chemotherapy in colon cancer
Mark Lewis shared a post on X, about paper published in Journal of Clinical Oncology:…
Sep 26, 2024, 09:30 | Insight
Erman Akkus: Neoadjuvant CRT vs. ChT for initially unresectable locally advanced ‘Colon’ cancer
Erman Akkus posted on X: “Neoadjuvant CRT vs. ChT for initially unresectable locally advanced ‘Colon’…
Sep 23, 2024, 19:45 | Blog
Marielle’s advocacy work is making a real difference in the cancer community - National Coalition for Cancer Survivorship
Marielle McLeod shared a post by National Coalition for Cancer Survivorship on LinkedIn: "Thank you,…
Sep 21, 2024, 14:08 | Blog
Rasha Aboelhassan: Neoadjuvant chemotherapy for localized colon cancer
Rasha Aboelhassan shared a post on LinkedIn: ''Jenny Seligmann. Neoadjuvant chemotherapy therapy for localized colon…
Sep 21, 2024, 13:13 | Blog
Florian Lordick: Niche2 data presented by Myriam Chalabi
Florian Lordick, Professor of Medicine at University of Leipzig and Director of the Comprehensive Cancer…
Sep 20, 2024, 13:05 | Insight
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer
Top Biomedical Science shared a post on X about a recent paper by Peter de…
Sep 18, 2024, 09:51 | Blog
Sumanta K. Pal: Plenty of terrific microbiome based presentations at ESMO24
Sumanta K. Pal shared a post on X: ''While I've been principally focused on genitourinary…
Sep 17, 2024, 08:49 | Blog
Annalice Gandini has been awarded with the prestigious ESMO Merit Travel Grant
Annalice Gandini shared on LinkedIn: "I am honoured to have had the opportunity to present…
Sep 14, 2024, 17:44 | Blog
Sylvester researchers are investigating the increase in colon cancer cases among younger adults
Sylvester Comprehensive Cancer Center shared on Linkedin: ''A rising health concern is affecting young adults…
Sep 12, 2024, 14:42 | Insight
Colon Cancer Treatment: NICHE-2 Validates Immunotherapy
Maria Babak shared a post by The Babak Lab on LinkedIn: “ This research highlights…
Sep 10, 2024, 04:33 | Blog
Elias Karam: ACCENT pooled analysis published in JCO
Elias Karam, Hematology and Medical Oncology Fellow at Gustave Roussy, shared a post on LinkedIn…
Aug 28, 2024, 16:25 | Blog
Amol Akhade about USFDA approval of blood based colon cancer screening test
Amol Akhade posted on X: "Hello everyone, Do read my Opinon piece published on Oncology…
Aug 28, 2024, 04:55 | Blog
Phuong Ly Gallagher's journey with colon cancer for the last 17 years with Mark Kageyama
Mark Kageyama, Account Manager at 2BYourOwnHero, shared a post on LinkedIn: “Phuong Ly Gallagher has…
Aug 26, 2024, 15:27 | Blog
August 2024 Tip Sheet of Sylvester Comprehensive Cancer Center
This month’s tip sheet from Sylvester Comprehensive Cancer Center at the University of Miami Miller…
Aug 25, 2024, 14:14 | Insight
Patrick Hwu: How can we enhance the immune response against cancer metastases?
Patrick Hwu shared a post on LinkedIn: “How can we enhance the immune response against cancer…
Aug 17, 2024, 19:56 | Insight
Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara Üniversitesi Tıp Fakültesi, a post on X: "Oncotype…
Aug 13, 2024, 13:55 | Blog
Lisa A. Lacasse: ACS CAN urges Congress to pass the Clinical Trial Modernization Act
Lisa A. Lacasse shared a post by ACS CAN on LinkedIn: "American Cancer Society Cancer…
Aug 8, 2024, 03:46 | Blog
From Diagnosis to Recovery: A Teacher's Story of Hope and Resilience
Colorectal Cancer Alliance posted on X: " 'In April of 2023, at the age of…
Aug 3, 2024, 10:49 | Insight
10-gene biomarker that could predict whether colon cancer patients will benefit from adjuvant chemotherapy - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on LinkedIn: "We are proud to share that Sylvester's Dr.…
Aug 3, 2024, 00:15 | Insight
Chris Williams: New analysis of CD3/CD8 TILs in QUASAR trial
Chris Williams, Medical oncologist at Leeds Hospitals, shared on X: "Adjuvant chemotherapy decisions are complex…
Jul 30, 2024, 02:33 | Insight
Study by Sylvester Comprehensive Cancer Center Identifies Biomarker that Could Predict Whether Colon Cancer Patients Benefit from Chemotherapy
Many people with stage II or III colon cancer receive additional, or adjuvant, chemotherapy following…
Jul 30, 2024, 02:16 | Blog
Myriam Chalabi: Abstract titles for ESMO24 are now online!
Myriam Chalabi shared on X: ”Abstract titles for ESMO24 now online! Full NICHE-3 cohort (59…
Jul 29, 2024, 06:38 | Blog
Heart of a Warrior: Jennifer’s Triumphant Fight Against Cancer
Jennifer's story is a testament to strength and resilience. Faced with limited treatment options, she…
Jul 21, 2024, 17:02 | Stories
Mattew's story about finding strength and support in the fight against colon cancer
Colorectal Cancer Alliance shared on LinkedIn: "After feeling sick for a prolonged period of time,…
Jul 17, 2024, 02:26 | Insight
Patrick Hwu: When patients with solid tumors don’t respond to immunotherapy
Patrick Hwu shared a post on X about a recent paper by Maria Parkhurst et…
Jul 16, 2024, 15:18 | Blog
Kathy Baker: Wenora Johnson's powerful and compelling story
Kathy Baker, Founder and Executive Director at My Faulty Gene, shared on LinkedIn: "If you are…
Jul 10, 2024, 15:30 | Blog
Hagen Kennecke: First prospective trial to confirm benefit of adjuvant COX-2 in PIK3CA activated colon cancer
Hagen Kennecke, Section chief and Chief Health Officer of the OHSU Knight-Legacy Health Cancer Collaborative, shared…
Jul 7, 2024, 17:31 | Insight
Alarming rise of young adult colorectal cancer
Fight Colorectal Cancer shared on X: "The rise of young adult Colorectal Cancer is alarming.…
Jul 2, 2024, 09:22 | Societies
Inspired by engaging with the GI community at ESMOGI24 - Agenus
Agenus shared on LinkedIn: "That's a wrap on ESMOGI24! Our team was inspired by engaging…
Jul 2, 2024, 02:01 | Blog
Sergio Cifuentes Canaval: Exciting Advances in Immunotherapy for Colon Cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn: “Exciting Advances…
Jun 29, 2024, 00:48 | Blog
Jenny Seligmann: Privilege to share the stage with Jeanne Tie to discuss advances in localised colon cancer
Jenny Seligmann, Professor of Gastrointestinal and Translational Oncology and Honorary Consultant in Medical Oncology at…
Jun 28, 2024, 13:41 | Insight
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Agenus shared on their X page: "New data from the NEST clinical trial was presented…
Jun 28, 2024, 13:00 | Insight
Cathy Eng: Agenus with very promising data in early MSI-s/MSI-H colon cancer
Cathy Eng shared on X/Twitter: "Bot/Bal immunotherapy in colon cancer NEST 1/2. Agenus with very…
Jun 20, 2024, 13:02 | Stories
From full time patient to a physician- Colorectal Cancer Alliance
Colorectal Cancer Alliance shared a post on LinkedIn: “My name is Sachin. I am 41 years…
Jun 8, 2024, 14:45 | Dialogues
ASCO24 Updates: The Role of Neoadjuvant Treatment for MMR-Proficient/Deficient Colorectal Cancer
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jun 8, 2024, 06:59 | Blog
Results of the NICHE-2 trial show it to be highly effective in a subset of patients with colon cancer - The Netherlands Cancer Institute
The Netherlands Cancer Institute shared on Linkedin: “More succes for neoadjuvant immunotherapy: results of the…
Jun 8, 2024, 03:28 | Opinion
Udhayvir Grewal: NICHE2 out now in NEJM
Udhayvir Grewal, Hematology and Oncology Fellow at the University of Iowa Holden Comprehensive Cancer Center, shared…
Jun 8, 2024, 02:16 | Blog
Toni Choueiri: NICHE-2 by Myriam Chalabi published in NEJM
Toni Choueiri shared a post on X:             , "NICHE-2 published…
Jun 7, 2024, 14:08 | Blog
Mark Lewis: Myriam Chalabi reporting the NICHE-2 trial in NEJM
Mark Lewis shared on X:                 . "TLC: don't…
Jun 7, 2024, 08:23 | Blog
Myriam Chalabi: The results of the NICHE-2 study now published in NEJM
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
Jun 7, 2024, 01:18 | Insight
Giuseppe Curigliano: Congratulations to Myriam Chalabi on her outstanding paper
Giuseppe Curigliano shared a post by NEJM on X: "Congratulations to Myriam Chalabi on her outstanding…
12
All: 122 Posts: 1 - 100
Special Coverage